Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Samuel C. Augustine"'
Autor:
David M. Scott, Samuel C. Augustine, Michelle Heffelfinger, Kathy Ward, Timothy R. McGuire, Yen Nyugen, Melissa Leybold
Publikováno v:
Clinical Research and Regulatory Affairs. 24:49-59
Objective: A survey was designed to assess the burden of acquiring medications in low-income Nebraska women.Methods: The survey was mailed to 23,000 women. Questions asked evaluated health status, prescription drug coverage, income, and impact associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75ebaedb981054dff21d58a1e59d60b2
https://doi.org/10.1080/10601330701316971
https://doi.org/10.1080/10601330701316971
Publikováno v:
The Diabetes Educator. 32:385-393
Purpose The specific aim of this project was to form a partnership between a community health center (CHC) to improve access to exercise for low-income patients with type 2 diabetes. Methods Eligible participants were members of the Siouxland Communi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::171b04a15860ee870050b05bb2a87295
https://doi.org/10.1177/0145721706288070
https://doi.org/10.1177/0145721706288070
Publikováno v:
Seminars in Oncology. 30:39-49
Radioimmunotherapy with radiolabeled anti-CD20 antibodies is a promising new treatment approach for low-grade non-Hodgkin's lymphoma. However, the administration of radiolabeled antibodies presents some added complexity. At the University of Nebraska
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6afb5dbd45eb54f874f46a2cc489be4
https://doi.org/10.1053/sonc.2003.23801
https://doi.org/10.1053/sonc.2003.23801
Publikováno v:
Seminars in Oncology. 30:39-49
Radioimmunotherapy with radiolabeled anti-CD20 antibodies is a promising new treatment approach for low-grade non-Hodgkin's lymphoma. However, the administration of radiolabeled antibodies presents some added complexity. At the University of Nebraska
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3f8a544346bdc055d37c636e5ef09a9
https://doi.org/10.1016/s0093-7754(03)70056-6
https://doi.org/10.1016/s0093-7754(03)70056-6
Autor:
David A. Jacobson, Julie M. Vose, Margaret A. Tempero, David Colcher, Jeffrey P. Norenberg, Lisa S. Gobar, Maribeth Hohenstein, Frank J. Rutar, Samuel C. Augustine, Valorie J. Dukat
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 42:93-100
Objective To describe the application of pharmaceutical care practices in the administration of new therapeutic radiopharmaceuticals used in the treatment of non-Hodgkin’s lymphoma (NHL). Practice Description At the Antibody Labeling Facility at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f4a99673316b26c5725338906737b0f
https://doi.org/10.1331/108658002763538125
https://doi.org/10.1331/108658002763538125
Autor:
David Colcher, James R. Anderson, Glenn V. Dalrymple, Katherine A. Harrison, Peter K. Leichner, Samuel C. Augustine, James L. Wisecarver, J Schlam, Margaret A. Tempero
Publikováno v:
Journal of Clinical Oncology. 15:1518-1528
PURPOSE A phase I trial that evaluated for extrahematopoietic toxicity was conducted with iodine-131 (131I) labeled monoclonal antibody (MAb) CC49. Correlative studies included pharmacokinetic and biodistribution analyses, estimates of absorbed radia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a965a22478cad2437c78b855dd03ad82
https://doi.org/10.1200/jco.1997.15.4.1518
https://doi.org/10.1200/jco.1997.15.4.1518
Autor:
Samuel C. Augustine, Ryuichi Kawatsu, Ignacio Blanco, Katherine A. Harrison, Peter K. Leichner, Margaret A. Tempero, David Colcher, Janina Baranowska-Kortylewicz
Publikováno v:
Journal of Clinical Immunology. 17:96-106
The immune response of 42 gastrointestinal and ovarian cancer patients at 1 month after exposure to murine monoclonal antibodies (B72.3 and CC49) reactive with the tumor-associated antigen TAG-72 was studied. The incidence of human anti-mouse antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe08ec552340a9fb4b9f31db9cfc2c2b
https://doi.org/10.1023/a:1027396714623
https://doi.org/10.1023/a:1027396714623
Autor:
Jonathan L. Vennerstrom, Dennis H. Robinson, Jon C. Wagner, Samuel C. Augustine, Donald W. Miller
Creatine supplements have a long history of use for improving muscle performance. While there are a number of studies that document the effects of creatine supplementation on muscle strength and performance, there are relatively few studies examining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::424b92cb5f58f4a6ad5f3f9ab53bb558
https://doi.org/10.1016/b978-0-12-396454-0.00040-0
https://doi.org/10.1016/b978-0-12-396454-0.00040-0
Publikováno v:
Journal of the American Pharmacists Association. 43:646-648
1. TechneScan MAG3 kit [package insert]. St. Louis, Mo: Mallinckrodt Inc; 2000. 2. OctreoScan kit [package insert]. St. Louis, Mo: Mallinckrodt Inc; 2000. 3. Weber DA, Paras P, Harris CC, et al. Initial testing and quality control for radionuclide do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2d63c6701e475e7ca1c58b58e4a742
https://doi.org/10.1331/154434503322452319
https://doi.org/10.1331/154434503322452319
Autor:
Robert P. Shrewsbury, Karen Nagel, Jennifer Adams, Christine R. Birnie, Dipan Ray, Kelly L. Scolaro, James H. Ruble, Samuel C. Augustine
Publikováno v:
American journal of pharmaceutical education. 76(7)
In August 2009, the American Association of Colleges of Pharmacy (AACP) Council of Sections established a Task Force to assess the current status of compounding education at its member institutions and to provide recommendations for future direction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf442462b6e75015e3857d872948954
https://pubmed.ncbi.nlm.nih.gov/23049115
https://pubmed.ncbi.nlm.nih.gov/23049115